Quick Answer
Phathom Pharmaceuticals, Inc. reported Stockholders Equity of -$438.17 million for fiscal year 2025.
Phathom Pharmaceuticals, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$438.17M | -72.8% |
| 2024 | -$253.58M | -248.5% |
| 2023 | -$72.76M | +2.7% |
| 2022 | -$74.81M | -203.7% |
| 2021 | $72.16M | -62.9% |
| 2020 | $194.27M | -14.8% |
| 2019 | $227.96M | +17825.9% |
| 2018 | -$1.29M | — |
| 2017 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$422.53M | -125.8% | -4.1% |
| June 30, 2025 | -$405.83M | -73.6% | -19.9% |
| March 31, 2025 | -$338.38M | -127.9% | -33.4% |
| December 31, 2024 | -$253.58M | -248.5% | -35.5% |
| September 30, 2024 | -$187.11M | -952.8% | +20.0% |
| June 30, 2024 | -$233.83M | -1428.6% | -57.5% |
| March 31, 2024 | -$148.50M | -64.6% | -104.1% |
| December 31, 2023 | -$72.76M | +2.7% | -309.4% |
- Phathom Pharmaceuticals, Inc. showed a decrease of -72.8% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Phathom Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: